202 related articles for article (PubMed ID: 17723219)
1. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.
Lim JH; Stirling B; Derry J; Koga T; Jono H; Woo CH; Xu H; Bourne P; Ha UH; Ishinaga H; Xu H; Andalibi A; Feng XH; Zhu H; Huang Y; Zhang W; Weng X; Yan C; Yin Z; Briles DE; Davis RJ; Flavell RA; Li JD
Immunity; 2007 Aug; 27(2):349-60. PubMed ID: 17723219
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A.
Song M; Teng Z; Li M; Niu X; Wang J; Deng X
J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019
[TBL] [Abstract][Full Text] [Related]
4. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
García-Suárez Mdel M; Cima-Cabal MD; Flórez N; García P; Cernuda-Cernuda R; Astudillo A; Vázquez F; De los Toyos JR; Méndez FJ
Infect Immun; 2004 Aug; 72(8):4534-40. PubMed ID: 15271913
[TBL] [Abstract][Full Text] [Related]
5. Cylindromatosis (CYLD) inhibits Streptococcus pneumonia-induced plasminogen activator inhibitor-1 expression via interacting with TRAF-6.
Wu J; Zhao J; Yu J; Zhang W; Huang Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):942-7. PubMed ID: 26056944
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
Dessing MC; Florquin S; Paton JC; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet-activating factor in pneumolysin-induced acute lung injury.
Witzenrath M; Gutbier B; Owen JS; Schmeck B; Mitchell TJ; Mayer K; Thomas MJ; Ishii S; Rosseau S; Suttorp N; Schütte H
Crit Care Med; 2007 Jul; 35(7):1756-62. PubMed ID: 17522574
[TBL] [Abstract][Full Text] [Related]
8. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
9. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
Ferreira DM; Arêas AP; Darrieux M; Leite LC; Miyaji EN
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2.
Lim JH; Ha U; Sakai A; Woo CH; Kweon SM; Xu H; Li JD
BMC Immunol; 2008 Jul; 9():40. PubMed ID: 18664270
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.
Orihuela CJ; Gao G; Francis KP; Yu J; Tuomanen EI
J Infect Dis; 2004 Nov; 190(9):1661-9. PubMed ID: 15478073
[TBL] [Abstract][Full Text] [Related]
13. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia.
Witzenrath M; Gutbier B; Hocke AC; Schmeck B; Hippenstiel S; Berger K; Mitchell TJ; de los Toyos JR; Rosseau S; Suttorp N; Schütte H
Crit Care Med; 2006 Jul; 34(7):1947-54. PubMed ID: 16715037
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.
Xue L; Igaki T; Kuranaga E; Kanda H; Miura M; Xu T
Dev Cell; 2007 Sep; 13(3):446-54. PubMed ID: 17765686
[TBL] [Abstract][Full Text] [Related]
15. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
[TBL] [Abstract][Full Text] [Related]
16. Role of p38 mitogen-activated protein kinase in posttraumatic immunosuppression in mice.
Ding N; Dahlke K; Janze AK; Mailer PC; Maus R; Bohling J; Welte T; Bauer M; Riedemann NC; Maus UA
J Trauma Acute Care Surg; 2012 Oct; 73(4):861-8. PubMed ID: 22914078
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pneumoniae-Induced Oxidative Stress in Lung Epithelial Cells Depends on Pneumococcal Autolysis and Is Reversible by Resveratrol.
Zahlten J; Kim YJ; Doehn JM; Pribyl T; Hocke AC; García P; Hammerschmidt S; Suttorp N; Hippenstiel S; Hübner RH
J Infect Dis; 2015 Jun; 211(11):1822-30. PubMed ID: 25512625
[TBL] [Abstract][Full Text] [Related]
18. Balancing mucosal immunity: caught between CYLD and Charybdis.
Kolls JK
Immunity; 2007 Aug; 27(2):187-9. PubMed ID: 17723213
[TBL] [Abstract][Full Text] [Related]
19.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
20. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.
Jefferies JM; Johnston CH; Kirkham LA; Cowan GJ; Ross KS; Smith A; Clarke SC; Brueggemann AB; George RC; Pichon B; Pluschke G; Pfluger V; Mitchell TJ
J Infect Dis; 2007 Sep; 196(6):936-44. PubMed ID: 17703426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
